Related Experiment Video
Updated: Jan 25, 2026

Bone Marrow-derived Macrophage Production
Published on: November 22, 2013
CTLA4-Ig Directly Inhibits Osteoclastogenesis by Interfering With Intracellular Calcium Oscillations in Bone Marrow
Hiroyuki Okada1, Hiroshi Kajiya2, Yasunori Omata1
1Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan.
Insights
Cytotoxic T-lymphocyte antigen 4-immunoglobulin (CTLA4-Ig) inhibits osteoclast differentiation by suppressing intracellular calcium oscillations dependent on Fc receptor gamma (FcRγ). This mechanism downregulates NFATc1 expression in bone marrow macrophages.
Area of Science:
- Immunology
- Cell Biology
- Rheumatology
Background:
- Rheumatoid arthritis is treated with CTLA4-Ig (Abatacept), which blocks T cell activation.
- Previous studies suggest CTLA4-Ig inhibits osteoclast differentiation, but the mechanism remains unclear.
Purpose of the Study:
- To elucidate the inhibitory mechanism of CTLA4-Ig on osteoclast differentiation.
- To investigate the role of Fc receptor gamma (FcRγ) in CTLA4-Ig's effects on osteoclastogenesis.
Main Methods:
- Bone marrow macrophages (BMMs) from wild-type (WT) and FcRγ-deficient mice were cultured with M-CSF and RANKL, with or without CTLA4-Ig.
- Intracellular calcium oscillations were measured using fura-2 staining.
- Osteoclast differentiation and NFATc1 expression were assessed.
- An LPS-induced osteolysis model was used to evaluate in vivo effects.
Main Results:
- CTLA4-Ig inhibited osteoclast differentiation and reduced NFATc1 expression in WT BMMs.
- CTLA4-Ig suppressed intracellular calcium oscillations in BMMs.
- These effects were dependent on FcRγ, as CTLA4-Ig did not significantly impact osteoclastogenesis or calcium oscillations in FcRγ-deficient BMMs.
- In vivo, CTLA4-Ig suppressed LPS-induced bone resorption in WT mice but not in FcRγ-deficient mice.
Conclusions:
- CTLA4-Ig inhibits osteoclast differentiation by suppressing FcRγ-dependent intracellular calcium oscillations.
- This mechanism involves the downregulation of NFATc1 expression in bone marrow macrophages.
- FcRγ is crucial for the osteoclast inhibitory effects of CTLA4-Ig both in vitro and in vivo.
Abstract:
CTLA4-Ig (cytotoxic T-lymphocyte antigen 4-immunoglobulin; Abatacept) is a biologic drug for rheumatoid arthritis. CTLA4 binds to the CD80/86 complex of antigen-presenting cells and blocks the activation of T cells. Although previous reports showed that CTLA4-Ig directly inhibited osteoclast differentiation, the whole inhibitory mechanism of CTLA4-Ig for osteoclast differentiation is unclear. Bone marrow macrophages (BMMs) from WT mice were cultured with M-CSF and RANKL with or without the recombinant mouse chimera CTLA4-Ig. Intracellular calcium oscillations of BMMs with RANKL were detected by staining with calcium indicator fura-2 immediately after administration of CTLA4-Ig or after one day of treatment. Calcium oscillations were analyzed using Fc receptor gamma- (FcRγ-) deficient BMMs. CTLA4-Ig inhibited osteoclast differentiation and reduced the expression of the nuclear factor of activated T cells NFATc1 in BMMs in vitro. Calcium oscillations in BMMs were suppressed by CTLA4-Ig both immediately after administration and after one day of treatment. CTLA4-Ig did not affect osteoclastogenesis and did not cause remarkable changes in calcium oscillations in FcRγ-deficient BMMs. Finally, to analyze the effect of CTLA4-Ig in vivo, we used an LPS-induced osteolysis model. CTLA4-Ig suppressed LPS-induced bone resorption in WT mice, not in FcRγ-deficient mice. In conclusion, CTLA4-Ig inhibits intracellular calcium oscillations depending on FcRγ and downregulates NFATc1 expression in BMMs. © 2019 American Society for Bone and Mineral Research.
More Related Videos
10:07Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
06:53Author Spotlight: Developing a Reproducible Method for Isolating Bone Marrow-Derived Macrophages from Neonatal Mice to Advance Early Life Immune Responses
Published on: May 24, 2024
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Small interfering RNAs (siRNA)
Feedback Inhibition
Oscillations In An LC Circuit
Forced Oscillations